-
2024-515162-13-00
5
2025-04-29
Eosinophilic Asthma
-
2023-506512-40-00
5
2025-04-16
Acute Kidney Injury
-
2023-506601-19-00
6
2025-04-15
transplantation
-
2024-517582-16-00
5
2025-04-14
rapid sequence induction in the operating room
-
2023-504086-23-00
5
2025-03-27
Subjects with PBC with a non-optimal response to UDCA.
-
2024-514804-14-00
6
2025-03-26
Liver transplantation
-
2023-503326-39-00
5
2025-03-06
Synchronous oligometastatic non-small cell lung cancer (NSCLC)
-
2024-512442-41-00
9
2024-12-03
Colorectal Carcinoma, Biliary Tract Carcinoma, Hepatocellular Carcinom
-
2024-512895-36-00
5
2024-11-25
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
2024-512113-41-00
5
2024-11-20
Severe Asthma
-
2023-509912-27-00
5
2024-11-07
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal
-
2022-502972-22-00
5
2024-10-31
Clostridioides difficile infection.
-
2023-510395-31-00
5
2024-10-30
Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Compensat
-
2023-509340-10-00
5
2024-10-29
Patients with HLA-A2 positive phenotype and metastatic Non-Small Cell
-
2024-516101-23-00
5
2024-10-28
Sarcoidosis
-
2023-504755-26-00
4
2024-10-21
Bronchiectasis
-
2024-514610-13-00
5
2024-10-04
patients suffering from acute myocarditis confirmed on Cardiac magneti
-
2023-504986-22-00
5
2024-09-30
surgical antibiotic prophylaxis
-
2022-502155-65-00
5
2024-07-30
Extra pulmonary sarcoidosis
-
2023-508260-30-01
5
2024-07-30
Patients with poor prognostic OVARian cancers based on the tumor prima
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-505112-38-00
11
2024-07-01
recently active non-infectious intermediate, posterior, and pan-uveiti
-
2023-508100-38-00
5
2024-06-24
Advanced Biliary Cancer (ABC)
-
2023-506721-11-00
5
2024-06-04
Familial Mediterranean Fever (FMF)